Supplements

Ipamorelin (5MG)

• 32/100 science score
• $49.99 price
• Promoted by Ben Greenfield

Overview

Effectiveness rated low due to robust animal data (e.g., PubMed 9849822: GH Emax 65 ng/mL in swine; PubMed 10373343: dose-dependent bone growth 42-52 microm/day in rats at 18-450 mcg/day) but scant human evidence—no proven benefits beyond transient GH pulse (1999 trial) and failed ileus RCT (PubMed 25331030: no p<0.05 outcomes). Safety moderate from trial tolerability but penalized for FDA ban proposal (immunogenicity, no SC PK data, GH risks) and lack of long-term studies. Quality low: no third

Key strengths

• Selective GH secretagogue with minimal cortisol/ACTH impact vs GHRP-6
• Mild side effects in limited human trial
• Affordable per dose (~$0.20-0.50 at 200mcg)

Our analysis

Avoid Ipamorelin due to lack of FDA approval, limited human evidence beyond GH pulsatile release, and significant regulatory risks including proposed compounding ban. Safer approved GH therapies exist for deficiencies. Not recommended for supplements/muscle/anti-aging without medical supervision.

Frequently asked questions

Is Ipamorelin (5MG) worth buying?

Ipamorelin (5MG) has a Verify Influencers trust score of 32/100 based on ingredient quality, clinical evidence, and third-party testing.

What is the trust score for Ipamorelin (5MG)?

Ipamorelin (5MG) scored 32 out of 100 in our science-backed analysis, which evaluates ingredient dosages against clinical literature and manufacturing transparency.

Browse all scored products · How products are scored